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Purpose: To analyse clinical data including aetiology, age, antecedents, classification and mortality in human status epilepticus
(SE), and to assess prognostic factors for mortality.
Methods: A prospective study was performed, including detailed analysis of clinical and laboratorial data of SE in individuals
of any age, except neonates.
Results: One hundred and eleven SE were included, with patients’ age ranging from 3 months to 98 years. SE incidence peaked
in the first year of life, and 59.4% of the individuals had previous epilepsy while 40.6% had not. The main underlying causes were
noncompliance to treatment in the first group, and CNS infection, stroke and metabolic disturbances in the second group. Overall
mortality was 19.8%, and deaths were correlated to aetiology and patient’s age. Refractory SE affected 11.7% of the cases.
Clinical types included focal, secondarily generalised and generalised SE. Clinical and clinicoelectrographic classifications were
convergent, but EEG was essential for the diagnosis in 4.5% of the cases.
Conclusions: Epileptic patients are at greater risk to develop SE, however, individuals with no prior history of epilepsy and
acute neurological problems can also present SE. Aetiology varies with patient’s age, and mortality is high and related to age
and underlying causes. Clinical and clinicoelectrographic classifications are usually convergent, but in some cases the diagnosis
of SE would not be established without the EEG.
© 2003 BEA Trading Ltd. Published by Elsevier Science Ltd. All rights reserved.
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INTRODUCTION
Status epilepticus (SE) is well recognised as a medical
emergency that requires prompt treatment, especially
its convulsive types. Despite recent improvements in
its diagnosis and treatment1–7, SE is still associated
with significant mortality8–10.
The diagnosis of SE is not difficult when motor signs
are overt. However, this happens in only part of the
patients and other clinical types still pose serious di-
agnostic challenges. This is the case, for example, for
the condition known as subtle SE11 or for the com-
plex partial SE that is more prevalent than previously
considered12–14. More recently it has been addition-
ally demonstrated that after the control of convulsive
SE, 14% of the patients still persist in nonconvulsive
SE15.
Besides these diagnostic difficulties other points
remain unclear, including the relative incidence of
distinct clinical presentations16, 17 and the prognostic
factors for outcome18–20. Mortality related to the pro-
longed seizure per se is low and in the range of 1–2%,
but varies depending upon the underlying causes and
the duration of the follow up21. In prospective popu-
lation studies this rate reaches 22%22, with increasing
incidence and mortality in the last 30 years due to the
occurrence of myoclonic SE after cardiac arrest23.
Some investigators have observed that longer seizure
duration24, continuous seizure activity25 or specific
EEG patterns26, 27 correlate with increased mortal-
ity, while others found that patient’s age and aetiol-
ogy were more related to outcome than specific ictal
patterns28. This article specifically addresses the main
clinical aspects of SE and their role in the outcome.
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PATIENTS AND METHODS
Patients
In this study we included all cases of partial and gener-
alised SE admitted to the Emergency Unit (EU) of the
Ribeirão Preto University Hospital, São Paulo, Brazil,
from 1989 to 1993. Neonatal SE was not included
and patients with incomplete and/or insufficient infor-
mation in their charts were also excluded from the
analysis.
Methods
The following data were obtained from each patient:
age, sex, previous history of epilepsy, aetiology, clin-
ical and EEG presentation, treatment and mortality.
The aetiologies were defined based on clinical and
ancillary examinations. Noncompliance to antiepilep-
tic drug (AED) treatment was defined based exclu-
sively on anamnesis data. The following definitions
were used in this study:
Clinical SE
SE was defined as an epileptic seizure whose dura-
tion was equal to or greater than 30 minutes or as re-
current seizures without recovery of consciousness in
between.
Electrographic SE
Presence of an ictal EEG pattern in at least 80% of
the recording time which lasted 30 minutes or longer.
Clinical classification
Classification based on the International Classification
of Epileptic Seizures (ILAE, 1981). SE was then di-
vided into three groups: (a) focal—consisting of focal
seizures; (b) focal with secondary generalisation—
consisting of generalised seizures and evidences of
preceding clinical focal seizures (clinical history
and/or ancillary examinations); and (c) generalised—
generalised seizures without any evidence of prior
focal seizures.
Statistical analysis
For statistical comparison of the data we calculated
the confidence intervals and considered the differences
as nonsignificant when intersection between intervals
occurred, and as significant when there was no inter-
section between them. The level of significance was
established at P < 0.05. For comparison of ages be-
tween the two groups of epileptic patients and indi-
viduals with no prior history of epilepsy we used the
nonparametric Kruskal–Wallis test. To assess the clin-
ical and electrographic classifications we applied the
kappa (K) statistic in order to verify the degree of con-
cordance between the clinical and EEG diagnosis. We
considered a K index of 0 < K < 0.4 as low con-
cordance, 0.41 < K < 0.75 as high concordance and
K > 0.75 as very high concordance.
RESULTS
Between 1989 and 1993, 111 SE (102 patients) were
diagnosed at the EU, including 9 recurrent SE in 7 pa-
tients that had two to three episodes of SE, indicating
that 6.8% of the patients had recurrent SE. All cases
had at least one ictal or immediate postictal EEG.
Age and sex
The distribution of patients by age and sex is shown
in Fig. 1. There were 53.9% males (55 patients) and
46.1% females (47 patients). Their ages ranged from
3 months to 98 years, with a mean of 34.1 years and
a median of 33.0 years. SE predominated in adults,
however, when compared per year, there was an inci-
dence peak in the first year of life.
Aetiology of SE
The patients were subdivided into two groups: group
A consisting of epileptic patients (66 patients, 59.4%)
and group B of individuals with no previous history
of epilepsy (45 patients, 40.5%). The list of aetiolo-
gies included AED noncompliance, AED changes,
metabolic disturbances, CNS infections, stroke, fever,
CNS structural lesions, systemic infections, cardiac
arrest, eclampsy, alcoholic intoxication, miscellaneous
and undetermined aetiologies. In the group A the main
causes were AED noncompliance (21 patients, 31.8%)
and undetermined aetiology (26 cases, 39.3%), P <
0.05. In group B three aetiologies predominated: CNS
infections (12 cases, 26.6%); stroke (11 cases, 24.4%);
and metabolic disturbances (8 cases, 17.7%), P<0.05.
Age-specific aetiology
For this analysis we subdivided the patients into four
age groups: (a) infants (1–12 months): 8 cases, 7.2%;
(b) children and adolescents (1–19 years): 29 cases,
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Fig. 1: Distribution of SE patients per age groups showing predominance of adult cases, but incidence peak in the first year of life.
Table 1: Distribution of aetiologies in different age groups.
Aetiology Group A, previous history Group B, no previous history Total of cases
of epilepsy (%) of epilepsy (%) (%)
Age group: 4 months to 1 year
Metabolic – 3 (37.5) 3 (37.5)
Hypoxia – 1 (12.5) 1 (12.5)
CNS infection – 3 (37.5) 3 (37.5)
Miscellaneous – 1 (12.5) 1 (12.5)
Age group: 1–19 years
3 (10.3) – 3 (10.3)
Undetermined 11 (37.9)∗ 1 (3.4) 12 (41.3)
AED noncompliance 1 (3.4) – 1 (3.4)
Fever 5 (17.2) 1 (3.4) 6 (20.7)
Systemic infection 1 (3.4) – 1 (3.4)
Cardiac arrest 2 (6.8) – 2 (6.8)
CNS structural lesion – 1 (3.4) 1 (3.4)
CNS infection – 1 (3.4) 1 (3.4)
Eclampsy – 1 (3.4) 1 (3.4)
Miscellaneous – 1 (3.4) 1 (3.4)
Age group: 20–59 years
AED noncompliance 18 (32.1)∗ – 18 (32.1)
AED prescription changes 1 (1.8) – 1 (1.8)
Metabolic 3 (5.3) 2 (3.5) 5 (8.9)
Stroke∗∗ – 5 (8.9) 5 (8.9)
CNS infection∗∗ – 6 (10.7) 6 (10.7)
CNS structural lesion – 2 (3.5) 2 (3.5)
Systemic infection 1 (1.8) – 1 (1.8)
Alcohol – 1 (1.8) 1 (1.8)
Undetermined 13 (23.2)∗ 1 (1.8) 14 (25)
Miscellaneous 2 (3.5) 1 (1.8) 3 (5.3)
Age group: 60–98 years
Stroke∗∗ – 6 (33.3) 6 (33.3)
Metabolic 1 (5.5) 3 (16.4) 4 (22.2)
CNS infection – 2 (11.1) 2 (11.1)
AED noncompliance 2 (11.1) – 2 (11.1)
Undetermined 2 (11.1) – 2 (11.1)
Miscellaneous – 2 (11.1) 2 (11.1)
∗ P < 0.05 within the group. ∗∗ P < 0.05 between groups.
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26.1%; (c) adults (20–59 years): 56 cases, 50.4%; and
(d) elderly (60–98 years): 18 cases, 16.2% (Table 1).
In the first year of life all children belonged to group
B. In the group of 29 children and adolescents, 23
(79.3%) were previously epileptic (P < 0.05) and 6
(20.6%) had no previous epilepsy. In this age range
the main aetiologies in group A were undetermined
aetiology (P < 0.05), followed by fever and AED
changes. Among the group of 56 adult patients with
SE, 38 (67.8%) had a previous diagnosis of epilepsy,
and 18 (32.1%) had not (P < 0.05). The main aeti-
ologies were irregular use of AED and undetermined
cause in group A (P < 0.05), while in group B there
was no predominant aetiology. In the group of older
patients only 27.7% belonged to group A, and the re-
maining 72.2% to group B (P < 0.05), with stroke
being the main aetiology in this last group of patients
(P < 0.05).
SE clinical types
In this series, 48.6% of the cases had focal SE, 18.9%
secondarily generalised SE and 19.8% generalised SE.
It was impossible to classify based exclusively on clin-
ical data in nine cases (8.1%), four of them with gen-
eralised motor signs and five nonconvulsive SE. The
Fig. 2: Male, 52 years, 12 hours of nonconvulsive status only diagnosed after EEG showing intermixed rhythmic slow and
sharp waves.
clinical history was not suggestive of SE in these last
five cases (4.5%), and their diagnosis was only estab-
lished after EEG recording. (Figs 2 and 3).
SE clinical types and EEG data
The EEG contributed to the clinical classification of
nine cases previously considered as unclassified SE.
Of these, four patients were initially thought to have
generalised SE with bilateral motor manifestations,
but their EEG showed ictal patterns regionalised or
hemispheric, allowing their inclusion in the group of
focal and secondarily generalised SE. Five patients
had nonconvulsive SE and their EEG allowed to in-
clude three of them in the group of nonconvulsive
generalised SE, and the remaining two in the noncon-
vulsive focal SE.
In order to compare the clinical and clinicoelec-
trographic classifications, we calculated the K index
to assess the degree of concordance between the two
classifications. There was a high degree of concor-
dance between them, 0.41 < K < 0.75, but the EEG
was essential for the diagnosis in 4.5% of the cases.
Among the group of focal SE, the complex par-
tial type predominated and was found in 52 (50%)
cases (P < 0.05). The secondarily generalised SE was
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Fig. 3: Same patient, EEG 24 hours later, after diazepan and phenytoin injections. Patient already conscious, and EEG
showing only residual background slow activity.
diagnosed in 29 cases (27.9%), all of them evolv-
ing from the complex partial type. Complex partial
SE alone, with and without secondary generalisation
reached a total of 77.9% of the cases.
Clinical features
The simple partial SE consisted of motor and visual
phenomenology. The motor signs started in the face of
one of the patients and further evolved to the ipsilateral
arm, while in the other two patients, only the upper
extremities were affected. The visual symptomatology
was described as colourful balls, scintillate scotoma,
scene hallucination and macropsia.
The complex partial SE group stood out not only for
the high number of cases but also for its distinct clin-
ical features. This group was additionally subdivided
into two subgroups: (a) subgroup I consisting of 36
patients whose impairment of consciousness was ex-
clusively attributed to the SE itself and (b) subgroup II
consisting of 45 cases in which, in addition to the SE,
the underlying aetiologies could also be playing a role
in the determination of the impairment of conscious-
ness. In these patients this overlap of factors further
aggravated or even delayed the diagnosis of SE.
Out of the total of 81 cases of complex partial SE,
71 presented in addition to the impairment of con-
sciousness, masticator automatisms and motor mani-
festations including eyelid myoclonia, eye and/or head
deviation, and face and/or limb tonic or clonic con-
traction. These signs were observed in 30 patients of
subgroup I and in 41 of subgroup II. The other 10 pa-
tients presented exclusively impairment of conscious-
ness: 6 of subgroup I and 4 of subgroup II.
The group of generalised SE included absence
seizures with unresponsiveness and eyelid myoclonia,
multifocal or generalised myoclonic seizures, axial
tonic seizures with eyes opening and turning up, hy-
perextension of the neck and eventually arms, and
cases with generalised tonic–clonic seizures.
Age, aetiology and mortality
There were 22 deaths. The total mortality in relation
to the number of episodes was 19.8% and in relation
to the number of patients, 21.2%. Considering the dif-
ferent age groups, the number of deaths in relation
to the number of patients in each group is shown in
Fig. 4. The percentage of deaths among the elderly
was greater than in any other age groups. The most
frequent aetiologies leading to deaths were stroke, in-
fection of CNS and miscellaneous factors (Fig. 5),
all affecting the group with no previous history of
epilepsy.
Refractory SE
In 13 cases (11.7%), the SE did not stop with first and
second choice drugs (benzodiazepines, phenytoin and
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Fig. 4: Percentage of deaths per age groups (∗P < 0.05).
Fig. 5: Cause of deaths in relation to patient groups.
phenobarbital), thus, characterising the refractory SE.
When we correlated aetiologies to the need of bar-
biturate coma induction, we found six cases of CNS
infection, two of stroke, two of cardiac arrest, one of
eclampsy, one of metabolic disturbance and one of un-
determined cause. This correlation was more frequent
among those patients with CNS infections.
DISCUSSION
The incidence of SE varies from 4 to 16% depending
upon the population studied21. People with epilepsy
represent an important risk group, but many SE also
occur among individuals with no previous history of
epilepsy, during systemic diseases and acute neuro-
logical problems. In more extended studies includ-
ing epileptic as well as nonepileptic persons the inci-
dence rates varied from 0.02 to 1.3%29, 30, but more
recent population data demonstrated that SE is not as
rare as previously supposed, with an overall incidence
rate of 41 cases/100 000 inhabitants/year8, 22, and of
17.1/100 000/year when only adults are considered.
This incidence was higher—54.5/100 000—in those
aged 60 years and older31.
This was an ample study that included different age
groups and diverse clinical types of SE, excluding
only the neonatal SE. There was no significant differ-
ence between sexes. Regarding age distribution, we
observed only one peak of incidence in the first year
of life, contradicting the previously proposed bimodal
distribution with two peaks of incidence, one in the
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first year of life and the other in patients over 60
years8, 22.
Regarding the aetiology most patients had previ-
ous diagnosis of epilepsy (59.4%) and irregular use
of AED represented the main cause of SE in the
group of patients with previous epilepsy, while CNS
infection, stroke and metabolic disturbances were the
main aetiologies among the patients with no previ-
ous history of epilepsy. Overall, our data on aetiol-
ogy and age groups are concordant with other series
in the literature32, 33. In children CNS infection and
metabolic disturbances represented the main causes of
SE34, while in individuals over 60 years cerebrovas-
cular disease, head trauma, metabolic disturbances,
brain tumours, CNS infection, undetermined aetiol-
ogy and miscellaneous factors were the most common
causes35.
One aetiology that was probably underestimated in
our study was compliance to treatment due to the fact
that systematic checking of AED levels was not al-
ways possible in the EU. Some cases of noncompli-
ance could then go undetected and be included in the
group of undetermined cause, and this fact could prob-
ably explain the large number of cases of adult SE of
undetermined aetiology.
The overall mortality rate was 19.8%, and the high-
est mortality was observed among the elderly, with
death affecting 55.5% of the aged patients. Besides
age itself, other factors probably contributed to mor-
tality, including aetiologies that frequently aggravated
the clinical condition of the patients. This possibil-
ity is somehow reinforced by the observation that SE
mortality among epileptic patients in this age group
was much lower when compared to aetiologies, such
as stroke and CNS infection that were mostly preva-
lent in those patients over 60 years.
In the literature, the mortality rate is also variable
depending on the aetiology of SE, with figures as high
as 58%36 and as low as 1–2% when considering deaths
strictly related to the prolonged seizure21. In series
including all age groups and all aetiologies the overall
mortality reaches 22%, being lower in children (2.5%),
moderate in adults (14%) and higher in the elderly
(38%), as recently demonstrated22.
Refractory SE was observed in 13 cases (11.7%) and
46.1% of them were related to CNS infection, again
suggesting that aetiology is an important determinant
of morbidity and mortality, independent of patient age.
In contrast to previous findings that considered gen-
eralised convulsive SE as the most prevalent type in
adults37, in our study we observed a predominance of
focal SE. This is in good agreement with other series
that reported generalised SE in patients with previous
history of focal epilepsy and aetiologies compatible
with focal SE, suggesting in reality secondarily gen-
eralised SE38–41.
We should emphasise that since the 1970s some
studies have already reported the predominance of fo-
cal SE in adults36, 42, and this observation has also
been confirmed in more recent studies8, 22. Most likely
conceptual and terminology problems are involved,
with authors possibly lumping together generalised
and secondarily generalised SE in a single category.
Among the group of focal SE, the complex par-
tial type predominated. We should stress, however,
that distinction between simple and complex partial
seizures is easier than simple and complex partial SE,
since impairment of consciousness which is a funda-
mental criterion to differentiate simple from complex
partial seizure is intrinsically part of the definition of
SE. Moreover, many other factors contribute to im-
pairment of consciousness, including different aetiolo-
gies and sedative medications frequently used to stop
seizures. In our group of patients with complex partial
SE, the impairment of consciousness could be exclu-
sively due to the SE itself in only 36 patients. Most
of these cases were related to previous epilepsy and
noncompliance to AED treatment. In the remaining 45
patients aetiology could also be playing a role in caus-
ing impairment of consciousness, including metabolic
disturbances, stroke and miscellaneous factors. This
group of patients obviously requires greater attention
since diagnosis of SE can be frequently delayed and
only suspected after the appearance of convulsive mo-
tor signs.
Among the 81 cases of complex partial SE, 71 (29
secondarily generalised) presented discrete motor phe-
nomena consisting of automatisms, eyelid or facial
myoclonia, head or eye deviation or even limb hy-
pertonia. Only 10 cases had isolated disturbance of
consciousness. These cases have been called subtle
convulsive generalised SE11, a terminology proposed
to classify cases with unusual rhythmic movements,
sometimes continuously involving the eyelids, face,
mouth, nistagmoid movements of the eyes, trunk or
members jerks occurring in patients with stupor or
deep coma. The EEG in these cases showed bilateral
ictal discharges which led to their inclusion in the
group of generalised SE. The same group later ob-
served that in general there was an asymmetry in the
EEG recordings which led them to reconsider these
cases as secondarily generalised SE43.
Subtle SE is generally considered as a late evolution
of SE, or a situation that occurs associated with severe
encephalopathies. In this study, we did not consider
the diagnosis of subtle SE since we did not have late
evolution of SE and it was not always found within
the context of a serious encephalopathy. We, therefore,
preferred the term complex partial SE to designate
these cases.
In many instances seizure semiology alone is insuffi-
cient to define the case. A previous history of epilepsy,
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EEG recording as well as imaging data are frequently
necessary for syndromic and aetiologic classification.
For example, a previously health patient with a focal
lesion, continuous stupor and generalised EEG dis-
charges, most likely can be better classified as having a
nonconvulsive focal than generalised SE, considering
the presence of the lesion and the low likelihood that
an adult patient who never had generalised epilepsy
would present a nonconvulsive generalised SE.
Complex partial SE is probably more frequent than
previously thought. It is frequently misdiagnosed
particularly when expressing isolated impairment of
consciousness and when associated with aetiologies
that could, by themselves, cause patient unresponsive-
ness (CNS infection, stroke, metabolic disturbances).
These cases have probably been classified within
other groups, causing underestimation of the real fig-
ure of this type of SE, as previously suggested44–46.
Instead of three categories, i.e. generalised, focal and
unilateral SE47, the most recent proposal for classifi-
cation indicates that SE should be classified into only
two categories, generalised and focal SE48. The first
group should be further subclassified into generalised
tonic–clonic, clonic, absence, tonic and myoclonic SE,
while the focal SE would encompass epilepsia par-
tialis continua of Kojevnikov, aura continua, limbic
SE (psychomotor status) and finally, hemiconvulsive
status with hemiparesis. This new proposal appears to
be more adequate, however, we should still consider
the fact that not all focal nonconvulsive SE can be in-
cluded in the classical limbic SE.
The diagnosis of generalised SE is usually not
difficult, except for patients with epileptic en-
cephalopathies and severe mental retardation whose
impairment of consciousness related to cluster of
atypical absences or absence status is frequently dif-
ficult to assess. A detailed clinical history carefully
comparing baseline behaviour, presence of eyelid
myoclonia and increase of EEG discharges is essen-
tial for the differentiation between interictal and ictal
states.
In general, there was good agreement between clini-
cal and clinicoelectrographic classifications. However,
the inclusion of EEG additionally defined nine cases
of unclassifiable SE, and was essential for the diag-
nosis of five cases (4.5%), similar to another study
where EEG was fundamental for the diagnosis of SE
in up to 8% of patients in coma17.
EEG was also of fundamental importance to fol-
low the evolution of all cases. Since the recovery
of consciousness is improbable immediately after
the initiation of treatment, and many other factors
can contribute to stupor, confusion, somnolence and
coma, continuous monitoring would predictably be
useful to assess continuation or resolution of SE in
a more sensitive way than on clinical grounds alone.
This would certainly benefit patients avoiding un-
necessary prolongation of aggressive treatment with
sedative drugs in some cases, and more importantly,
avoiding delayed diagnosis of nonconvulsive SE.
In conclusion, SE occurred in epileptic as well
as in nonepileptic individuals. The main aetiologies
were AED noncompliance in the first group, and
CNS infections, stroke and metabolic disturbances
in the group of individuals with no previous history
of epilepsy which mainly included very young (first
year of life) and elderly (above 60 years) patients.
It predominated in adults, but the incidence peaked
in the first year of life. Complex partial SE, with
or without secondary generalisation, predominated.
Mortality was related to underlying aetiology and age,
and was higher in the elderly. Finally, the EEG was
instrumental for the classification and evolution of
SE, and most importantly, essential for the diagnosis
under certain circumstances.
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